ALS DRUG SQUEAKS THROUGH FDA PANEL

被引：0

|

作者：

BARNETT, AA

机构：

来源：

LANCET | 1995年 / 346卷 / 8979期

关键词：

D O I：

10.1016/S0140-6736(95)92731-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：897 / 897

页数：1

相关论文

共 50 条

[11] DRUG POLICY - FDA PANEL BACKS INTERLEUKIN-2
CULLITON, BJ
NATURE, 1992, 355 (6358) : 287 - 287
[12] FDA panel says preterm birth drug should be withdrawn
Jaffe, Susan
LANCET, 2022, 400 (10362): : 1501 - 1501
[13] FDA panel advises against omeprazole as over the counter drug
Gottlieb, S
BRITISH MEDICAL JOURNAL, 2000, 321 (7269): : 1099 - 1099
[14] FDA approves first new ALS drug in over 20 years
Asher Mullard
Nature Reviews Drug Discovery, 2017, 16 : 375 - 375
[15] FDA approves first new ALS drug in over 20 years
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (06) : 375 - 375
[16] Harvard squeaks through oncomouse patent appeal
Alison Abbott
Nature, 2001, 414 : 241 - 241
[17] FDA panel advises against cold drug, citing concerns over drug interactions
Cimons, M
ASM NEWS, 2002, 68 (06): : 263 - 264
[18] Harvard squeaks through oncomouse patent appeal
Abbott, A
NATURE, 2001, 414 (6861) : 241 - 241
[19] Food and Drug Administration - Panel issues plea to boost FDA research
Marshall, E
SCIENCE, 1998, 280 (5368) : 1341 - 1341
[20] Senate panel approves drug user fee, FDA overhaul bill
不详
CHEMICAL & ENGINEERING NEWS, 1997, 75 (25) : 23 - 23

← 1 2 3 4 5 →